Health services platforms rarely come together quickly. Building one out usually takes five to seven years, and a clinical integration component can stretch that further, which puts the sector at odds with the four-to-five-year clocks most sponsor funds run on.

He works that mismatch as managing partner of Lupine Crest Capital. He underwrites healthcare at the pace the operating reality demands, not the pace a fund vintage dictates. JP Conte has spent decades in the sector, long enough to know where its deals tend to break.

Demand That Keeps Compounding

Healthcare has been a structural growth sector for as long as JP Conte has invested, and 2026 has not altered the basic case. Aging demographics, cost pressure, and the push to integrate care continue to drive deals.

PwC’s September 2025 analysis found health systems and insurers pursuing acquisitions that widen care delivery, pharmacy, and technology platforms, with integrated AI-based care models as the goal. Private equity keeps building in physician practice management, behavioral health, and tech-enabled services alongside them.

Why Hold Flexibility Is the Edge

Sponsor-led healthcare deals run on shorter clocks than the assets actually need. A platform mid-build can land on the market simply because a fund reached the end of its life, not because the company finished its growth.

Lupine Crest’s freedom to hold lets Conte buy those half-finished platforms and see them through. Sector tenure compounds the advantage, since years of underwriting health services teach a buyer which integration risks are survivable and which sink a deal.

The Family Office Fit

Patient capital and healthcare suit each other because both reward time. A buyer measured against a fund-level return target prices the exit first; a balance-sheet buyer prices the build.

JP Conte’s read is that depth and duration win the sector over a full cycle. Healthcare has paid patient owners across prior cycles, and the 2026 outlook offers no signal that the pattern is about to reverse. A buyer that can match its hold period to a platform’s actual build-out captures value the seller left on the table, which is the part of healthcare investing that rewards staying power over speed.